aluates Reports

$ 0.0

Automative

Global Alzheimer's Disease Drug Market Insights, Forecast to 2030

Published Date: July 2024

Report Code: QYRE-Auto-27H11910

Global Alzheimer s Disease Drug Market Size Manufacturers Supply Chain Sales Channel and Clients 2022 2028

BUY CHAPTERS

Global Alzheimer's Disease Drug Market Insights, Forecast to 2030

Code: QYRE-Auto-27H11910

Report

July 2024

Pages:94

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Daiichi Sankyo

Merz Pharma

Pfizer Inc

Johnson & Johnson

Lundbeck

Allergan plc

Novartis

Eisai Co Ltd

Alzheimer's Disease Drug Market Size

The global Alzheimer's Disease Drug market is projected to grow from US$ 3676.9 million in 2024 to US$ 4020.5 million by 2030, at a Compound Annual Growth Rate (CAGR) of 1.5% during the forecast period.

Alzheimer's Disease Drug Market

Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.

The major players in global Alzheimer’s Disease Drug market include Allergan, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson, Lundbeck, etc. The top 3 players hold over 60% of global shares. Europe and North America are main markets, they occupy over 70% of the global market. Memantine and Donepezil are the main types, with a share about 70%. Early to Moderate Stages is the key application, which covers over 55% shares.

Report Covers:

This report presents an overview of global market for Alzheimer's Disease Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Alzheimer's Disease Drug, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Alzheimer's Disease Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Alzheimer's Disease Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Alzheimer's Disease Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Alzheimer's Disease Drug sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Alzheimer's Disease Drug Market Report

Report Metric	Details
Report Name	Alzheimer's Disease Drug Market
Accounted market size in 2024	US$ 3676.9 million
Forecasted market size in 2030	US$ 4020.5 million
CAGR	1.5
Base Year	2024
Forecasted years	2024 - 2030
Segment by Type	Donepezil Memantine Rivastigmine Others
Segment by Application	Early to Moderate Stages Moderate to Severe Stages
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson, Lundbeck
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Alzheimer's Disease Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Alzheimer's Disease Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Alzheimer's Disease Drug sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Alzheimer's Disease Drug Market growing?

Ans: The Alzheimer's Disease Drug Market witnessing a CAGR of 1.5 during the forecast period 2024-2030.

What is the Alzheimer's Disease Drug Market size in 2030?

Ans: The Alzheimer's Disease Drug Market size in 2030 will be US$ 4020.5 million.

What is the market share of major companies in Alzheimer's Disease Drug Market?

Ans: The top 3 players hold over 60% of global shares.

What is the Alzheimer's Disease Drug Market share by region?

Ans: Europe and North America are main markets, they occupy over 70% of the global market.

What is the Alzheimer's Disease Drug Market share by type?

Ans: Memantine and Donepezil are the main types, with a share about 70%.

What is the Alzheimer's Disease Drug Market share by application?

Ans: Early to Moderate Stages is the key application, which covers over 55% shares.

Who are the main players in the Alzheimer's Disease Drug Market report?

Ans: The main players in the Alzheimer's Disease Drug Market are Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson, Lundbeck

What are the Application segmentation covered in the Alzheimer's Disease Drug Market report?

Ans: The Applications covered in the Alzheimer's Disease Drug Market report are Early to Moderate Stages, Moderate to Severe Stages

What are the Type segmentation covered in the Alzheimer's Disease Drug Market report?

Ans: The Types covered in the Alzheimer's Disease Drug Market report are Donepezil, Memantine, Rivastigmine, Others

1 Study Coverage

1.1 Alzheimer's Disease Drug Product Introduction

1.2 Market by Type

1.2.1 Global Alzheimer's Disease Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Donepezil

1.2.3 Memantine

1.2.4 Rivastigmine

1.2.5 Others

1.3 Market by Application

1.3.1 Global Alzheimer's Disease Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Early to Moderate Stages

1.3.3 Moderate to Severe Stages

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Alzheimer's Disease Drug Sales Estimates and Forecasts 2019-2030

2.2 Global Alzheimer's Disease Drug Revenue by Region

2.2.1 Global Alzheimer's Disease Drug Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Alzheimer's Disease Drug Revenue by Region (2019-2024)

2.2.3 Global Alzheimer's Disease Drug Revenue by Region (2025-2030)

2.2.4 Global Alzheimer's Disease Drug Revenue Market Share by Region (2019-2030)

2.3 Global Alzheimer's Disease Drug Sales Estimates and Forecasts 2019-2030

2.4 Global Alzheimer's Disease Drug Sales by Region

2.4.1 Global Alzheimer's Disease Drug Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Alzheimer's Disease Drug Sales by Region (2019-2024)

2.4.3 Global Alzheimer's Disease Drug Sales by Region (2025-2030)

2.4.4 Global Alzheimer's Disease Drug Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Alzheimer's Disease Drug Sales by Manufacturers

3.1.1 Global Alzheimer's Disease Drug Sales by Manufacturers (2019-2024)

3.1.2 Global Alzheimer's Disease Drug Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Alzheimer's Disease Drug in 2023

3.2 Global Alzheimer's Disease Drug Revenue by Manufacturers

3.2.1 Global Alzheimer's Disease Drug Revenue by Manufacturers (2019-2024)

3.2.2 Global Alzheimer's Disease Drug Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Alzheimer's Disease Drug Revenue in 2023

3.3 Global Key Players of Alzheimer's Disease Drug, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Alzheimer's Disease Drug Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Alzheimer's Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Alzheimer's Disease Drug, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Alzheimer's Disease Drug, Product Offered and Application

3.8 Global Key Manufacturers of Alzheimer's Disease Drug, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Alzheimer's Disease Drug Sales by Type

4.1.1 Global Alzheimer's Disease Drug Historical Sales by Type (2019-2024)

4.1.2 Global Alzheimer's Disease Drug Forecasted Sales by Type (2025-2030)

4.1.3 Global Alzheimer's Disease Drug Sales Market Share by Type (2019-2030)

4.2 Global Alzheimer's Disease Drug Revenue by Type

4.2.1 Global Alzheimer's Disease Drug Historical Revenue by Type (2019-2024)

4.2.2 Global Alzheimer's Disease Drug Forecasted Revenue by Type (2025-2030)

4.2.3 Global Alzheimer's Disease Drug Revenue Market Share by Type (2019-2030)

4.3 Global Alzheimer's Disease Drug Price by Type

4.3.1 Global Alzheimer's Disease Drug Price by Type (2019-2024)

4.3.2 Global Alzheimer's Disease Drug Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Alzheimer's Disease Drug Sales by Application

5.1.1 Global Alzheimer's Disease Drug Historical Sales by Application (2019-2024)

5.1.2 Global Alzheimer's Disease Drug Forecasted Sales by Application (2025-2030)

5.1.3 Global Alzheimer's Disease Drug Sales Market Share by Application (2019-2030)

5.2 Global Alzheimer's Disease Drug Revenue by Application

5.2.1 Global Alzheimer's Disease Drug Historical Revenue by Application (2019-2024)

5.2.2 Global Alzheimer's Disease Drug Forecasted Revenue by Application (2025-2030)

5.2.3 Global Alzheimer's Disease Drug Revenue Market Share by Application (2019-2030)

5.3 Global Alzheimer's Disease Drug Price by Application

5.3.1 Global Alzheimer's Disease Drug Price by Application (2019-2024)

5.3.2 Global Alzheimer's Disease Drug Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Alzheimer's Disease Drug Market Size by Type

6.1.1 US & Canada Alzheimer's Disease Drug Sales by Type (2019-2030)

6.1.2 US & Canada Alzheimer's Disease Drug Revenue by Type (2019-2030)

6.2 US & Canada Alzheimer's Disease Drug Market Size by Application

6.2.1 US & Canada Alzheimer's Disease Drug Sales by Application (2019-2030)

6.2.2 US & Canada Alzheimer's Disease Drug Revenue by Application (2019-2030)

6.3 US & Canada Alzheimer's Disease Drug Market Size by Country

6.3.1 US & Canada Alzheimer's Disease Drug Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Alzheimer's Disease Drug Sales by Country (2019-2030)

6.3.3 US & Canada Alzheimer's Disease Drug Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Alzheimer's Disease Drug Market Size by Type

7.1.1 Europe Alzheimer's Disease Drug Sales by Type (2019-2030)

7.1.2 Europe Alzheimer's Disease Drug Revenue by Type (2019-2030)

7.2 Europe Alzheimer's Disease Drug Market Size by Application

7.2.1 Europe Alzheimer's Disease Drug Sales by Application (2019-2030)

7.2.2 Europe Alzheimer's Disease Drug Revenue by Application (2019-2030)

7.3 Europe Alzheimer's Disease Drug Market Size by Country

7.3.1 Europe Alzheimer's Disease Drug Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Alzheimer's Disease Drug Sales by Country (2019-2030)

7.3.3 Europe Alzheimer's Disease Drug Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Alzheimer's Disease Drug Market Size

8.1.1 China Alzheimer's Disease Drug Sales (2019-2030)

8.1.2 China Alzheimer's Disease Drug Revenue (2019-2030)

8.2 China Alzheimer's Disease Drug Market Size by Application

8.2.1 China Alzheimer's Disease Drug Sales by Application (2019-2030)

8.2.2 China Alzheimer's Disease Drug Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Alzheimer's Disease Drug Market Size by Type

9.1.1 Asia Alzheimer's Disease Drug Sales by Type (2019-2030)

9.1.2 Asia Alzheimer's Disease Drug Revenue by Type (2019-2030)

9.2 Asia Alzheimer's Disease Drug Market Size by Application

9.2.1 Asia Alzheimer's Disease Drug Sales by Application (2019-2030)

9.2.2 Asia Alzheimer's Disease Drug Revenue by Application (2019-2030)

9.3 Asia Alzheimer's Disease Drug Sales by Region

9.3.1 Asia Alzheimer's Disease Drug Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Alzheimer's Disease Drug Revenue by Region (2019-2030)

9.3.3 Asia Alzheimer's Disease Drug Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Alzheimer's Disease Drug Market Size by Type

10.1.1 Middle East, Africa and Latin America Alzheimer's Disease Drug Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Alzheimer's Disease Drug Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Alzheimer's Disease Drug Market Size by Application

10.2.1 Middle East, Africa and Latin America Alzheimer's Disease Drug Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Alzheimer's Disease Drug Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Alzheimer's Disease Drug Sales by Country

10.3.1 Middle East, Africa and Latin America Alzheimer's Disease Drug Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Alzheimer's Disease Drug Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Alzheimer's Disease Drug Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Allergan

11.1.1 Allergan Company Information

11.1.2 Allergan Overview

11.1.3 Allergan Alzheimer's Disease Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Allergan Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Allergan Recent Developments

11.2 Eisai

11.2.1 Eisai Company Information

11.2.2 Eisai Overview

11.2.3 Eisai Alzheimer's Disease Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 Eisai Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Eisai Recent Developments

11.3 Novartis

11.3.1 Novartis Company Information

11.3.2 Novartis Overview

11.3.3 Novartis Alzheimer's Disease Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 Novartis Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Novartis Recent Developments

11.4 Daiichi Sankyo

11.4.1 Daiichi Sankyo Company Information

11.4.2 Daiichi Sankyo Overview

11.4.3 Daiichi Sankyo Alzheimer's Disease Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Daiichi Sankyo Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Daiichi Sankyo Recent Developments

11.5 Merz Pharma

11.5.1 Merz Pharma Company Information

11.5.2 Merz Pharma Overview

11.5.3 Merz Pharma Alzheimer's Disease Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 Merz Pharma Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Merz Pharma Recent Developments

11.6 Pfizer

11.6.1 Pfizer Company Information

11.6.2 Pfizer Overview

11.6.3 Pfizer Alzheimer's Disease Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 Pfizer Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Pfizer Recent Developments

11.7 Johnson & Johnson

11.7.1 Johnson & Johnson Company Information

11.7.2 Johnson & Johnson Overview

11.7.3 Johnson & Johnson Alzheimer's Disease Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.7.4 Johnson & Johnson Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Johnson & Johnson Recent Developments

11.8 Lundbeck

11.8.1 Lundbeck Company Information

11.8.2 Lundbeck Overview

11.8.3 Lundbeck Alzheimer's Disease Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.8.4 Lundbeck Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Lundbeck Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Alzheimer's Disease Drug Industry Chain Analysis

12.2 Alzheimer's Disease Drug Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Alzheimer's Disease Drug Production Mode & Process

12.4 Alzheimer's Disease Drug Sales and Marketing

12.4.1 Alzheimer's Disease Drug Sales Channels

12.4.2 Alzheimer's Disease Drug Distributors

12.5 Alzheimer's Disease Drug Customers

13 Market Dynamics

13.1 Alzheimer's Disease Drug Industry Trends

13.2 Alzheimer's Disease Drug Market Drivers

13.3 Alzheimer's Disease Drug Market Challenges

13.4 Alzheimer's Disease Drug Market Restraints

14 Key Findings in The Global Alzheimer's Disease Drug Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Daiichi Sankyo

Merz Pharma

Pfizer Inc

Johnson & Johnson

Lundbeck

Allergan plc

Novartis

Eisai Co Ltd

List of Tables

Table 1. Global Alzheimer's Disease Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Donepezil

Table 3. Major Manufacturers of Memantine

Table 4. Major Manufacturers of Rivastigmine

Table 5. Major Manufacturers of Others

Table 6. Global Alzheimer's Disease Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 7. Global Alzheimer's Disease Drug Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 8. Global Alzheimer's Disease Drug Revenue by Region (2019-2024) & (US$ Million)

Table 9. Global Alzheimer's Disease Drug Revenue by Region (2025-2030) & (US$ Million)

Table 10. Global Alzheimer's Disease Drug Revenue Market Share by Region (2019-2024)

Table 11. Global Alzheimer's Disease Drug Revenue Market Share by Region (2025-2030)

Table 12. Global Alzheimer's Disease Drug Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 13. Global Alzheimer's Disease Drug Sales by Region (2019-2024) & (K Units)

Table 14. Global Alzheimer's Disease Drug Sales by Region (2025-2030) & (K Units)

Table 15. Global Alzheimer's Disease Drug Sales Market Share by Region (2019-2024)

Table 16. Global Alzheimer's Disease Drug Sales Market Share by Region (2025-2030)

Table 17. Global Alzheimer's Disease Drug Sales by Manufacturers (2019-2024) & (K Units)

Table 18. Global Alzheimer's Disease Drug Sales Share by Manufacturers (2019-2024)

Table 19. Global Alzheimer's Disease Drug Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 20. Global Alzheimer's Disease Drug Revenue Share by Manufacturers (2019-2024)

Table 21. Global Key Players of Alzheimer's Disease Drug, Industry Ranking, 2022 VS 2023 VS 2024

Table 22. Alzheimer's Disease Drug Price by Manufacturers 2019-2024 (USD/Unit)

Table 23. Global Alzheimer's Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 24. Global Alzheimer's Disease Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease Drug as of 2023)

Table 25. Global Key Manufacturers of Alzheimer's Disease Drug, Manufacturing Base Distribution and Headquarters

Table 26. Global Key Manufacturers of Alzheimer's Disease Drug, Product Offered and Application

Table 27. Global Key Manufacturers of Alzheimer's Disease Drug, Date of Enter into This Industry

Table 28. Mergers & Acquisitions, Expansion Plans

Table 29. Global Alzheimer's Disease Drug Sales by Type (2019-2024) & (K Units)

Table 30. Global Alzheimer's Disease Drug Sales by Type (2025-2030) & (K Units)

Table 31. Global Alzheimer's Disease Drug Sales Share by Type (2019-2024)

Table 32. Global Alzheimer's Disease Drug Sales Share by Type (2025-2030)

Table 33. Global Alzheimer's Disease Drug Revenue by Type (2019-2024) & (US$ Million)

Table 34. Global Alzheimer's Disease Drug Revenue by Type (2025-2030) & (US$ Million)

Table 35. Global Alzheimer's Disease Drug Revenue Share by Type (2019-2024)

Table 36. Global Alzheimer's Disease Drug Revenue Share by Type (2025-2030)

Table 37. Alzheimer's Disease Drug Price by Type (2019-2024) & (USD/Unit)

Table 38. Global Alzheimer's Disease Drug Price Forecast by Type (2025-2030) & (USD/Unit)

Table 39. Global Alzheimer's Disease Drug Sales by Application (2019-2024) & (K Units)

Table 40. Global Alzheimer's Disease Drug Sales by Application (2025-2030) & (K Units)

Table 41. Global Alzheimer's Disease Drug Sales Share by Application (2019-2024)

Table 42. Global Alzheimer's Disease Drug Sales Share by Application (2025-2030)

Table 43. Global Alzheimer's Disease Drug Revenue by Application (2019-2024) & (US$ Million)

Table 44. Global Alzheimer's Disease Drug Revenue by Application (2025-2030) & (US$ Million)

Table 45. Global Alzheimer's Disease Drug Revenue Share by Application (2019-2024)

Table 46. Global Alzheimer's Disease Drug Revenue Share by Application (2025-2030)

Table 47. Alzheimer's Disease Drug Price by Application (2019-2024) & (USD/Unit)

Table 48. Global Alzheimer's Disease Drug Price Forecast by Application (2025-2030) & (USD/Unit)

Table 49. US & Canada Alzheimer's Disease Drug Sales by Type (2019-2024) & (K Units)

Table 50. US & Canada Alzheimer's Disease Drug Sales by Type (2025-2030) & (K Units)

Table 51. US & Canada Alzheimer's Disease Drug Revenue by Type (2019-2024) & (US$ Million)

Table 52. US & Canada Alzheimer's Disease Drug Revenue by Type (2025-2030) & (US$ Million)

Table 53. US & Canada Alzheimer's Disease Drug Sales by Application (2019-2024) & (K Units)

Table 54. US & Canada Alzheimer's Disease Drug Sales by Application (2025-2030) & (K Units)

Table 55. US & Canada Alzheimer's Disease Drug Revenue by Application (2019-2024) & (US$ Million)

Table 56. US & Canada Alzheimer's Disease Drug Revenue by Application (2025-2030) & (US$ Million)

Table 57. US & Canada Alzheimer's Disease Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 58. US & Canada Alzheimer's Disease Drug Revenue by Country (2019-2024) & (US$ Million)

Table 59. US & Canada Alzheimer's Disease Drug Revenue by Country (2025-2030) & (US$ Million)

Table 60. US & Canada Alzheimer's Disease Drug Sales by Country (2019-2024) & (K Units)

Table 61. US & Canada Alzheimer's Disease Drug Sales by Country (2025-2030) & (K Units)

Table 62. Europe Alzheimer's Disease Drug Sales by Type (2019-2024) & (K Units)

Table 63. Europe Alzheimer's Disease Drug Sales by Type (2025-2030) & (K Units)

Table 64. Europe Alzheimer's Disease Drug Revenue by Type (2019-2024) & (US$ Million)

Table 65. Europe Alzheimer's Disease Drug Revenue by Type (2025-2030) & (US$ Million)

Table 66. Europe Alzheimer's Disease Drug Sales by Application (2019-2024) & (K Units)

Table 67. Europe Alzheimer's Disease Drug Sales by Application (2025-2030) & (K Units)

Table 68. Europe Alzheimer's Disease Drug Revenue by Application (2019-2024) & (US$ Million)

Table 69. Europe Alzheimer's Disease Drug Revenue by Application (2025-2030) & (US$ Million)

Table 70. Europe Alzheimer's Disease Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 71. Europe Alzheimer's Disease Drug Revenue by Country (2019-2024) & (US$ Million)

Table 72. Europe Alzheimer's Disease Drug Revenue by Country (2025-2030) & (US$ Million)

Table 73. Europe Alzheimer's Disease Drug Sales by Country (2019-2024) & (K Units)

Table 74. Europe Alzheimer's Disease Drug Sales by Country (2025-2030) & (K Units)

Table 75. China Alzheimer's Disease Drug Sales by Type (2019-2024) & (K Units)

Table 76. China Alzheimer's Disease Drug Sales by Type (2025-2030) & (K Units)

Table 77. China Alzheimer's Disease Drug Revenue by Type (2019-2024) & (US$ Million)

Table 78. China Alzheimer's Disease Drug Revenue by Type (2025-2030) & (US$ Million)

Table 79. China Alzheimer's Disease Drug Sales by Application (2019-2024) & (K Units)

Table 80. China Alzheimer's Disease Drug Sales by Application (2025-2030) & (K Units)

Table 81. China Alzheimer's Disease Drug Revenue by Application (2019-2024) & (US$ Million)

Table 82. China Alzheimer's Disease Drug Revenue by Application (2025-2030) & (US$ Million)

Table 83. Asia Alzheimer's Disease Drug Sales by Type (2019-2024) & (K Units)

Table 84. Asia Alzheimer's Disease Drug Sales by Type (2025-2030) & (K Units)

Table 85. Asia Alzheimer's Disease Drug Revenue by Type (2019-2024) & (US$ Million)

Table 86. Asia Alzheimer's Disease Drug Revenue by Type (2025-2030) & (US$ Million)

Table 87. Asia Alzheimer's Disease Drug Sales by Application (2019-2024) & (K Units)

Table 88. Asia Alzheimer's Disease Drug Sales by Application (2025-2030) & (K Units)

Table 89. Asia Alzheimer's Disease Drug Revenue by Application (2019-2024) & (US$ Million)

Table 90. Asia Alzheimer's Disease Drug Revenue by Application (2025-2030) & (US$ Million)

Table 91. Asia Alzheimer's Disease Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 92. Asia Alzheimer's Disease Drug Revenue by Region (2019-2024) & (US$ Million)

Table 93. Asia Alzheimer's Disease Drug Revenue by Region (2025-2030) & (US$ Million)

Table 94. Asia Alzheimer's Disease Drug Sales by Region (2019-2024) & (K Units)

Table 95. Asia Alzheimer's Disease Drug Sales by Region (2025-2030) & (K Units)

Table 96. Middle East, Africa and Latin America Alzheimer's Disease Drug Sales by Type (2019-2024) & (K Units)

Table 97. Middle East, Africa and Latin America Alzheimer's Disease Drug Sales by Type (2025-2030) & (K Units)

Table 98. Middle East, Africa and Latin America Alzheimer's Disease Drug Revenue by Type (2019-2024) & (US$ Million)

Table 99. Middle East, Africa and Latin America Alzheimer's Disease Drug Revenue by Type (2025-2030) & (US$ Million)

Table 100. Middle East, Africa and Latin America Alzheimer's Disease Drug Sales by Application (2019-2024) & (K Units)

Table 101. Middle East, Africa and Latin America Alzheimer's Disease Drug Sales by Application (2025-2030) & (K Units)

Table 102. Middle East, Africa and Latin America Alzheimer's Disease Drug Revenue by Application (2019-2024) & (US$ Million)

Table 103. Middle East, Africa and Latin America Alzheimer's Disease Drug Revenue by Application (2025-2030) & (US$ Million)

Table 104. Middle East, Africa and Latin America Alzheimer's Disease Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 105. Middle East, Africa and Latin America Alzheimer's Disease Drug Revenue by Country (2019-2024) & (US$ Million)

Table 106. Middle East, Africa and Latin America Alzheimer's Disease Drug Revenue by Country (2025-2030) & (US$ Million)

Table 107. Middle East, Africa and Latin America Alzheimer's Disease Drug Sales by Country (2019-2024) & (K Units)

Table 108. Middle East, Africa and Latin America Alzheimer's Disease Drug Sales by Country (2025-2030) & (K Units)

Table 109. Allergan Company Information

Table 110. Allergan Description and Major Businesses

Table 111. Allergan Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 112. Allergan Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 113. Allergan Recent Developments

Table 114. Eisai Company Information

Table 115. Eisai Description and Major Businesses

Table 116. Eisai Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 117. Eisai Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 118. Eisai Recent Developments

Table 119. Novartis Company Information

Table 120. Novartis Description and Major Businesses

Table 121. Novartis Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 122. Novartis Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 123. Novartis Recent Developments

Table 124. Daiichi Sankyo Company Information

Table 125. Daiichi Sankyo Description and Major Businesses

Table 126. Daiichi Sankyo Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 127. Daiichi Sankyo Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 128. Daiichi Sankyo Recent Developments

Table 129. Merz Pharma Company Information

Table 130. Merz Pharma Description and Major Businesses

Table 131. Merz Pharma Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 132. Merz Pharma Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 133. Merz Pharma Recent Developments

Table 134. Pfizer Company Information

Table 135. Pfizer Description and Major Businesses

Table 136. Pfizer Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 137. Pfizer Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 138. Pfizer Recent Developments

Table 139. Johnson & Johnson Company Information

Table 140. Johnson & Johnson Description and Major Businesses

Table 141. Johnson & Johnson Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 142. Johnson & Johnson Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 143. Johnson & Johnson Recent Developments

Table 144. Lundbeck Company Information

Table 145. Lundbeck Description and Major Businesses

Table 146. Lundbeck Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 147. Lundbeck Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 148. Lundbeck Recent Developments

Table 149. Key Raw Materials Lists

Table 150. Raw Materials Key Suppliers Lists

Table 151. Alzheimer's Disease Drug Distributors List

Table 152. Alzheimer's Disease Drug Customers List

Table 153. Alzheimer's Disease Drug Market Trends

Table 154. Alzheimer's Disease Drug Market Drivers

Table 155. Alzheimer's Disease Drug Market Challenges

Table 156. Alzheimer's Disease Drug Market Restraints

Table 157. Research Programs/Design for This Report

Table 158. Key Data Information from Secondary Sources

Table 159. Key Data Information from Primary Sources

List of Figures

Figure 1. Alzheimer's Disease Drug Product Picture

Figure 2. Global Alzheimer's Disease Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Alzheimer's Disease Drug Market Share by Type in 2023 & 2030

Figure 4. Donepezil Product Picture

Figure 5. Memantine Product Picture

Figure 6. Rivastigmine Product Picture

Figure 7. Others Product Picture

Figure 8. Global Alzheimer's Disease Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 9. Global Alzheimer's Disease Drug Market Share by Application in 2023 & 2030

Figure 10. Early to Moderate Stages

Figure 11. Moderate to Severe Stages

Figure 12. Alzheimer's Disease Drug Report Years Considered

Figure 13. Global Alzheimer's Disease Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Alzheimer's Disease Drug Revenue 2019-2030 (US$ Million)

Figure 15. Global Alzheimer's Disease Drug Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 16. Global Alzheimer's Disease Drug Revenue Market Share by Region (2019-2030)

Figure 17. Global Alzheimer's Disease Drug Sales 2019-2030 ((K Units)

Figure 18. Global Alzheimer's Disease Drug Sales Market Share by Region (2019-2030)

Figure 19. US & Canada Alzheimer's Disease Drug Sales YoY (2019-2030) & (K Units)

Figure 20. US & Canada Alzheimer's Disease Drug Revenue YoY (2019-2030) & (US$ Million)

Figure 21. Europe Alzheimer's Disease Drug Sales YoY (2019-2030) & (K Units)

Figure 22. Europe Alzheimer's Disease Drug Revenue YoY (2019-2030) & (US$ Million)

Figure 23. China Alzheimer's Disease Drug Sales YoY (2019-2030) & (K Units)

Figure 24. China Alzheimer's Disease Drug Revenue YoY (2019-2030) & (US$ Million)

Figure 25. Asia (excluding China) Alzheimer's Disease Drug Sales YoY (2019-2030) & (K Units)

Figure 26. Asia (excluding China) Alzheimer's Disease Drug Revenue YoY (2019-2030) & (US$ Million)

Figure 27. Middle East, Africa and Latin America Alzheimer's Disease Drug Sales YoY (2019-2030) & (K Units)

Figure 28. Middle East, Africa and Latin America Alzheimer's Disease Drug Revenue YoY (2019-2030) & (US$ Million)

Figure 29. The Alzheimer's Disease Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 30. The Top 5 and 10 Largest Manufacturers of Alzheimer's Disease Drug in the World: Market Share by Alzheimer's Disease Drug Revenue in 2023

Figure 31. Global Alzheimer's Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 32. Global Alzheimer's Disease Drug Sales Market Share by Type (2019-2030)

Figure 33. Global Alzheimer's Disease Drug Revenue Market Share by Type (2019-2030)

Figure 34. Global Alzheimer's Disease Drug Sales Market Share by Application (2019-2030)

Figure 35. Global Alzheimer's Disease Drug Revenue Market Share by Application (2019-2030)

Figure 36. US & Canada Alzheimer's Disease Drug Sales Market Share by Type (2019-2030)

Figure 37. US & Canada Alzheimer's Disease Drug Revenue Market Share by Type (2019-2030)

Figure 38. US & Canada Alzheimer's Disease Drug Sales Market Share by Application (2019-2030)

Figure 39. US & Canada Alzheimer's Disease Drug Revenue Market Share by Application (2019-2030)

Figure 40. US & Canada Alzheimer's Disease Drug Revenue Share by Country (2019-2030)

Figure 41. US & Canada Alzheimer's Disease Drug Sales Share by Country (2019-2030)

Figure 42. U.S. Alzheimer's Disease Drug Revenue (2019-2030) & (US$ Million)

Figure 43. Canada Alzheimer's Disease Drug Revenue (2019-2030) & (US$ Million)

Figure 44. Europe Alzheimer's Disease Drug Sales Market Share by Type (2019-2030)

Figure 45. Europe Alzheimer's Disease Drug Revenue Market Share by Type (2019-2030)

Figure 46. Europe Alzheimer's Disease Drug Sales Market Share by Application (2019-2030)

Figure 47. Europe Alzheimer's Disease Drug Revenue Market Share by Application (2019-2030)

Figure 48. Europe Alzheimer's Disease Drug Revenue Share by Country (2019-2030)

Figure 49. Europe Alzheimer's Disease Drug Sales Share by Country (2019-2030)

Figure 50. Germany Alzheimer's Disease Drug Revenue (2019-2030) & (US$ Million)

Figure 51. France Alzheimer's Disease Drug Revenue (2019-2030) & (US$ Million)

Figure 52. U.K. Alzheimer's Disease Drug Revenue (2019-2030) & (US$ Million)

Figure 53. Italy Alzheimer's Disease Drug Revenue (2019-2030) & (US$ Million)

Figure 54. Russia Alzheimer's Disease Drug Revenue (2019-2030) & (US$ Million)

Figure 55. China Alzheimer's Disease Drug Sales Market Share by Type (2019-2030)

Figure 56. China Alzheimer's Disease Drug Revenue Market Share by Type (2019-2030)

Figure 57. China Alzheimer's Disease Drug Sales Market Share by Application (2019-2030)

Figure 58. China Alzheimer's Disease Drug Revenue Market Share by Application (2019-2030)

Figure 59. Asia Alzheimer's Disease Drug Sales Market Share by Type (2019-2030)

Figure 60. Asia Alzheimer's Disease Drug Revenue Market Share by Type (2019-2030)

Figure 61. Asia Alzheimer's Disease Drug Sales Market Share by Application (2019-2030)

Figure 62. Asia Alzheimer's Disease Drug Revenue Market Share by Application (2019-2030)

Figure 63. Asia Alzheimer's Disease Drug Revenue Share by Region (2019-2030)

Figure 64. Asia Alzheimer's Disease Drug Sales Share by Region (2019-2030)

Figure 65. Japan Alzheimer's Disease Drug Revenue (2019-2030) & (US$ Million)

Figure 66. South Korea Alzheimer's Disease Drug Revenue (2019-2030) & (US$ Million)

Figure 67. China Taiwan Alzheimer's Disease Drug Revenue (2019-2030) & (US$ Million)

Figure 68. Southeast Asia Alzheimer's Disease Drug Revenue (2019-2030) & (US$ Million)

Figure 69. India Alzheimer's Disease Drug Revenue (2019-2030) & (US$ Million)

Figure 70. Middle East, Africa and Latin America Alzheimer's Disease Drug Sales Market Share by Type (2019-2030)

Figure 71. Middle East, Africa and Latin America Alzheimer's Disease Drug Revenue Market Share by Type (2019-2030)

Figure 72. Middle East, Africa and Latin America Alzheimer's Disease Drug Sales Market Share by Application (2019-2030)

Figure 73. Middle East, Africa and Latin America Alzheimer's Disease Drug Revenue Market Share by Application (2019-2030)

Figure 74. Middle East, Africa and Latin America Alzheimer's Disease Drug Revenue Share by Country (2019-2030)

Figure 75. Middle East, Africa and Latin America Alzheimer's Disease Drug Sales Share by Country (2019-2030)

Figure 76. Brazil Alzheimer's Disease Drug Revenue (2019-2030) & (US$ Million)

Figure 77. Mexico Alzheimer's Disease Drug Revenue (2019-2030) & (US$ Million)

Figure 78. Turkey Alzheimer's Disease Drug Revenue (2019-2030) & (US$ Million)

Figure 79. Israel Alzheimer's Disease Drug Revenue (2019-2030) & (US$ Million)

Figure 80. GCC Countries Alzheimer's Disease Drug Revenue (2019-2030) & (US$ Million)

Figure 81. Alzheimer's Disease Drug Value Chain

Figure 82. Alzheimer's Disease Drug Production Process

Figure 83. Channels of Distribution

Figure 84. Distributors Profiles

Figure 85. Bottom-up and Top-down Approaches for This Report

Figure 86. Data Triangulation

Figure 87. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions